Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the Company's patented and proprietary BIOREACTANCE technology. Clinicians use the NICOM for noninvasive, Goal Directed Fluid Management in critical and non-critical clinical environments. NICOM is FDA cleared and has received a CE Mark.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/04/13 | $14,500,000 |
Ascension Health Ventures MVM Partners Robert Bosch Venture Capital Springfield Investments | undisclosed | |
| 02/25/14 | $9,000,000 |
Ascension Health Ventures Fletcher Spaght Ventures MVM Partners Robert Bosch Venture Capital Springfield Investments | undisclosed | |
| 09/12/17 | $11,760,000 | Series C |
Fletcher Spaght Ventures HighCape Partners MVM Partners Robert Bosch Venture Capital Springfield Investments | undisclosed |
